Masaki Kawamura

Summary

Affiliation: Tohoku University
Country: Japan

Publications

  1. ncbi request reprint The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer
    Masaki Kawamura
    Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryo machi 4 1, Aoba ku, Sendai, Miyagi 980 8575, Japan
    Anticancer Res 34:651-8. 2014
  2. ncbi request reprint [Clinicopathological features of peripheral small-sized (2 cm or less in diameter) non-small cell lung cancer]
    Masaki Kawamura
    Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
    Kyobu Geka 65:11-6. 2012
  3. ncbi request reprint [The fluorodeoxyglucose-positron emission tomography (FDG-PET) findings and surgical strategy for pulmonary sclerosing hemangioma]
    Hisashi Oishi
    Department of Thoracic Surgery, Sendai Medical Center, Sendai, Japan
    Kyobu Geka 63:769-73. 2010

Detail Information

Publications3

  1. ncbi request reprint The prognostic significance of eukaryotic elongation factor 1 alpha-2 in non-small cell lung cancer
    Masaki Kawamura
    Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryo machi 4 1, Aoba ku, Sendai, Miyagi 980 8575, Japan
    Anticancer Res 34:651-8. 2014
    ..Eukaryotic elongation factor 1 alpha-2 (eEF1A2) has been recently shown to be a putative oncogene of lung cancer...
  2. ncbi request reprint [Clinicopathological features of peripheral small-sized (2 cm or less in diameter) non-small cell lung cancer]
    Masaki Kawamura
    Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
    Kyobu Geka 65:11-6. 2012
    ..0400). Multiple logistic regression analysis showed that solid adenocarcinoma and squamous cell carcinoma recurred more frequently than adenocarcinoma with GGO (p=0.0619, odds ratio 4.969, 95%CI 0.9242~37.67)...
  3. ncbi request reprint [The fluorodeoxyglucose-positron emission tomography (FDG-PET) findings and surgical strategy for pulmonary sclerosing hemangioma]
    Hisashi Oishi
    Department of Thoracic Surgery, Sendai Medical Center, Sendai, Japan
    Kyobu Geka 63:769-73. 2010
    ..The clinical features of the pulmonary sclerosing hemangioma are various. Therefore, the surgical treatment should be determined in each case carefully while considering the FDG-PET findings...